Mason987 - Latest News 2026-07-21T12:18:28+00:00 urn:uuid:3221a6a6-022b-d5f1-e427-344d25c614fb More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies. urn:uuid:5c13d74b-094b-7a5b-7895-f81f3ab117c6 2021-04-16T10:47:43+00:00 The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030 urn:uuid:519d92d5-fd7d-fe47-f32a-8b3a9a82f560 2021-04-16T10:13:49+00:00 Growing at an annualized rate of over 16.5%, urn:uuid:c45083e9-3359-70d7-da4f-7dbe5b24e50f 2021-04-16T10:09:08+00:00 ‘Patient Recruitment and Retention Services, 2019-2030’ urn:uuid:79bfac67-d4f4-a2f8-87f3-341e3c4342c0 2021-04-16T09:54:13+00:00 Presently, close to 140 companies claim to be actively engaged in offering patient recruitment urn:uuid:68758fde-1666-158c-a950-310c43c2ac3a 2021-04-16T09:48:43+00:00 Patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, urn:uuid:7177803a-0154-f8d8-3376-666cadaee141 2021-04-16T09:44:28+00:00 Patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, urn:uuid:d21fadb8-c134-7a98-21a5-20056d38f14d 2021-04-16T09:39:04+00:00 “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” urn:uuid:1271603b-8a6a-78e1-e5ba-03367b64c5e4 2021-04-09T08:05:10+00:00 The potential of nearly 300 next generation immune checkpoint modulators for the treatment (Roots Analysis) urn:uuid:f63ad969-05dd-d1fb-7f83-bdcdea48e7d0 2021-04-09T08:00:32+00:00 Inhibitors and stimulators market is projected to grow at an annualized rate of ~15% (till 2030) urn:uuid:7c281b83-379a-2c2b-62de-e94f87f320c7 2021-04-09T07:56:58+00:00 The next generation immune checkpoint inhibitors and stimulators market (Roots Analysis) urn:uuid:01a5801e-e99a-c7b9-eeee-c228976b03c5 2021-04-09T07:51:53+00:00 “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” urn:uuid:cf750554-777d-5bf9-09cf-1cd7bb2b546e 2021-04-09T07:45:34+00:00 Presently engaged in evaluating the clinical applications of over 180 cannabinoid-derivatives urn:uuid:d30a5402-dda2-b728-7bbf-a3b619f9c994 2021-04-09T07:41:56+00:00 The endocannabinoid system is projected to grow at an annualized rate of ~30%, (till 2030) urn:uuid:bc3fc67a-e35c-11ad-144b-743edeae66ad 2021-04-09T07:38:41+00:00 The endocannabinoid system targeted therapeutics market < Roots Analysis> urn:uuid:53a469e3-a9c6-75e4-ee24-0e4a87fcfde5 2021-04-09T07:32:45+00:00 Endocannabinoid system targeted therapeutics market is growing at an annualized rate of 30%, (Roots Analysis) urn:uuid:e04216e6-2a21-c628-857e-757fe44648e0 2021-04-09T07:29:13+00:00